Related Experiment Video
Updated: May 1, 2026
The Intra-Aortic Balloon Pump
Published on: February 5, 2021
Duration of intra-aortic balloon pump use and related complications
Konstantinos Dean Boudoulas1, Theodore Bowen, Andrew Pederzolli
1Division of Cardiovascular Medicine, Section of Interventional Cardiology, The Ohio State University Medical Center , Columbus, Ohio , USA.
Insights
Intra-aortic balloon pump (IABP) use in ST-elevation myocardial infarction (STEMI) patients is linked to complications. Prolonged IABP use (over two days) significantly increases the risk of vascular and bleeding complications.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Intra-aortic balloon pump (IABP) use is sometimes necessary for patients with ST-elevation myocardial infarction (STEMI) experiencing hemodynamic instability.
- However, IABP use is associated with potential complications.
Purpose of the Study:
- To investigate the relationship between the duration of IABP use and the incidence of vascular and bleeding complications in STEMI patients.
- To compare complication rates between patients with short-term (≤ 2 days) and longer-term (> 2 days) IABP support.
Main Methods:
- A retrospective study of 36 STEMI patients requiring IABP after percutaneous coronary intervention.
- Patients were divided into two groups based on IABP duration: ≤ 2 days (n=27) and > 2 days (n=9).
- Vascular complications and bleeding incidence were compared between the groups.
Main Results:
- Patients with IABP duration > 2 days experienced significantly higher rates of complications (66%) compared to those with duration ≤ 2 days (18%).
- Mean IABP duration was significantly longer in the complication group (4.1 days vs. 1.4 days).
- Mean duration of anticoagulation was also significantly longer in the > 2 day group.
Conclusions:
- Prolonged IABP use (exceeding two days) is associated with a significant increase in vascular and bleeding complications in STEMI patients.
- Findings suggest that limiting IABP duration may reduce complication rates.
- Further prospective studies with larger cohorts are recommended to confirm these findings.
Background:
Intra-aortic balloon pump (IABP) use may be associated with complications; however, in certain patients with ST-elevation myocardial infarction (STEMI) with hemodynamic instability refractory to medical management its use may become necessary.
Methods:
36 STEMI patients with IABP placement for hemodynamic instability after percutaneous coronary intervention were studied. IABP duration ranged from one to seven days (median two days). Based on median time, patients were divided into two groups: IABP duration ≤ 2 days (n = 27) or > 2 days (n = 9). Vascular complications and incidence of bleeding were compared.
Results:
Mean IABP duration was 1.4 ± 0.5 and 4.1 ± 1.3 days in ≤ 2 day and > 2 day groups, respectively (P < 0.01). Glycoprotein IIb/IIIa inhibitor and anti-coagulation use was not significantly different between groups. Mean duration of anti-coagulation was 1.9 ± 1.2 and 4.5 ± 1.3 days in ≤ 2 day and > 2 day groups, respectively (P < 0.05). Complications (vascular, access site bleeding, gastrointestinal bleeding) were significantly greater in > 2 day group (66%) compared to ≤ 2 day group (18%; P < 0.05).
Conclusions:
When an IABP was used for more than two days complications significantly increased. The clinical implications of the study will be strengthened if the findings are confirmed in a prospective study with a larger number of patients.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021